Hunan Hansen Pharmaceutical Co., Ltd. (SHE:002412)
China · Delayed Price · Currency is CNY 6.13
-0.09 (-1.45%)
Jun 11, 2026, 3:04 PM CST
SHE:002412 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Net Income | 225.27 | 198.12 | 220.24 | 205.01 | 167.62 | 134.85 |
Depreciation & Amortization | 40.23 | 40.23 | 40.76 | 50.97 | 51.59 | 51.19 |
Other Amortization | 1.28 | 1.28 | 0.72 | 0.72 | 0.71 | 0.71 |
Loss (Gain) From Sale of Assets | 0.02 | 0.02 | - | 0.02 | - | - |
Asset Writedown & Restructuring Costs | 3.26 | 3.26 | 0.17 | 0.27 | 47.52 | 40.96 |
Loss (Gain) From Sale of Investments | -8.19 | -8.19 | -12.05 | -62.95 | -92.71 | -68.3 |
Provision & Write-off of Bad Debts | 0 | 0 | -0.1 | -0.02 | 0.03 | -0.27 |
Other Operating Activities | -78.67 | 8.31 | 1.88 | 6.68 | 3.94 | 7.16 |
Change in Accounts Receivable | -6.37 | -6.37 | -110.32 | -61.77 | -35.83 | 14.34 |
Change in Inventory | 13.84 | 13.84 | 8.18 | 15.23 | -6.93 | -19.57 |
Change in Accounts Payable | -5.1 | -5.1 | -18.55 | 7.56 | 7.93 | 51.92 |
Operating Cash Flow | 185.55 | 245.38 | 130.78 | 160.95 | 143.81 | 212.54 |
Operating Cash Flow Growth | 16.20% | 87.62% | -18.74% | 11.92% | -32.34% | 29.99% |
Capital Expenditures | -9.99 | -11.1 | -11.64 | -19.48 | -11.5 | -229.34 |
Sale of Property, Plant & Equipment | 0.03 | 0.03 | 0 | 0.35 | 0.23 | 0.05 |
Investment in Securities | -76.2 | -85.6 | -38.27 | -64.44 | -96.07 | -48.84 |
Other Investing Activities | 3.3 | -76.94 | 17.71 | 22.01 | 33.85 | 106.49 |
Investing Cash Flow | -82.86 | -173.61 | -42.19 | -65.55 | -84.49 | -172.84 |
Short-Term Debt Issued | - | 56.06 | 84.38 | 105 | 150 | 131.62 |
Total Debt Issued | 56.06 | 56.06 | 84.38 | 105 | 150 | 131.62 |
Short-Term Debt Repaid | - | -83 | -95 | -130 | -161.62 | -178 |
Total Debt Repaid | -83 | -83 | -95 | -130 | -161.62 | -178 |
Net Debt Issued (Repaid) | -26.94 | -26.94 | -10.62 | -25 | -11.62 | -46.38 |
Issuance of Common Stock | - | - | - | - | 1.35 | - |
Common Dividends Paid | -1.65 | -1.73 | -2.55 | -154.67 | -4.07 | -6.58 |
Other Financing Activities | - | - | - | - | 0.12 | 0.02 |
Financing Cash Flow | -28.59 | -28.67 | -13.17 | -179.67 | -14.22 | -52.95 |
Net Cash Flow | 74.09 | 43.1 | 75.42 | -84.28 | 45.09 | -13.25 |
Free Cash Flow | 175.56 | 234.28 | 119.15 | 141.47 | 132.3 | -16.8 |
Free Cash Flow Growth | 18.20% | 96.63% | -15.78% | 6.93% | - | - |
Free Cash Flow Margin | 17.00% | 22.55% | 11.86% | 14.80% | 14.44% | -1.88% |
Free Cash Flow Per Share | 0.35 | 0.47 | 0.24 | 0.28 | 0.26 | -0.03 |
Cash Interest Paid | - | - | - | - | 0.08 | 0.19 |
Cash Income Tax Paid | 168.56 | 171.41 | 192.73 | 174.93 | 104.01 | 102.21 |
Levered Free Cash Flow | 139.68 | 187.9 | 39.5 | 81.48 | -25.92 | 49.24 |
Unlevered Free Cash Flow | 140.55 | 188.94 | 41.1 | 83.78 | -23.48 | 53.32 |
Change in Working Capital | 2.36 | 2.36 | -120.84 | -39.75 | -34.89 | 46.24 |